ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

KNR Bristol-Myers Squibb Company Corts TR Bristol Myers Squibb Corp Backed TR Secs CL A Ctf

27.81
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Bristol-Myers Squibb Company Corts TR Bristol Myers Squibb Corp Backed TR Secs CL A Ctf NYSE:KNR NYSE Ordinary Share
  Price Change % Change Share Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 27.81 0.00 00:00:00

- Current report filing (8-K)

06/02/2009 7:05pm

Edgar (US Regulatory)


UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

______________________________

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 2, 2009

 

Structured Products Corp.

on behalf of

 

CorTS Trust for Bristol-Myers Squibb Debentures

 

(Exact name of registrant as specified in its charter)

 

 

Delaware

001-32095

13-3692801

(State or other jurisdiction
of incorporation or
organization)

(Commission
File Number)

(IRS Employer
Identification
Number)

 

 

 

388 Greenwich Street
New York, New York

 

10013

 

(212) 816-7496

(Address of principal
executive offices)

(Zip Code)

(Registrant's
telephone number
including area code)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))

 

 

1


Section 8 - Other Events

 

Item 8.01 Other Events.

 

This current report on Form 8-K relates to a distribution made to holders of the Certificates issued by the CorTS Trust for Bristol-Myers Squibb Debentures.

 

The issuer of the underlying securities, or guarantor thereof, or successor thereto, as applicable, is subject to the information reporting requirements of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Periodic reports and other information required to be filed pursuant to the Exchange Act, by the issuer of the underlying securities, or guarantor thereof, or successor thereto, as applicable, may be inspected and copied at the public reference facilities maintained by the Securities and Exchange Commission (the "Commission") at 450 Fifth Street, N.W., Washington, D.C. 20549. The Commission also maintains a site on the World Wide Web at "http://www.sec.gov" at which users can view and download copies of reports, proxy and information statements and other information filed electronically through the Electronic Data Gathering, Analysis and Retrieval system. Neither Structured Products Corp. nor the trustee has participated in the preparation of such reporting documents, or made any due diligence investigation with respect to the information provided therein. Neither Structured Products Corp. nor the trustee has verified the accuracy or completeness of such documents or reports. There can be no assurance that events affecting the issuer of the underlying securities, or guarantor thereof, or successor thereto, as applicable, or the underlying securities have not occurred or have not yet been publicly disclosed which would affect the accuracy or completeness of the publicly available documents described above.

 

Underlying Securities Issuer(s) or
Guarantor, or successor thereto

 

Exchange Act File
Number

Bristol-Myers Squibb Company

001-01136

 

 

Section 9 - Financial Statements and Exhibits

 

Item 9.01 Financial Statements and Exhibits.

 

 

(c)

Exhibits:

 

 

1.

Trustee's Report with respect to the February 2, 2009 Distribution Date for the CorTS Trust for Bristol-Myers Squibb Debentures

 

 

2


 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

 

By:   /s/

   Stanley Louie

________________________________

 

Name:

   Stanley Louie

 

Title:

   Authorized Signatory

 

 

 

 

 

 

 

 

 

 

 

February 2, 2009

 

 

3


EXHIBIT INDEX

 

 

Exhibit

 

Page

1

Trustee's Report with respect to the February 2, 2009 Distribution Date for the CorTS Trust for Bristol-Myers Squibb Debentures

5

 

 

 

4


 

Exhibit   1

 

To the Holders of:

 

CorTS Trust for Bristol-Myers Squibb Debentures

6.80% Corporate-Backed Trust Securities (CorTS) Class A Certificates

*CUSIP:

22082B209

 

Class:

A

*CUSIP:

22082BAA8

 

Class:

B

 

U.S. Bank Trust National Association, as Trustee for the CorTS Trust for Bristol-Myers Squibb Debentures, hereby gives notice with respect to the Distribution Date of February 2, 2009 (the "Distribution Date") as follows:

 

1.

The amount of the distribution payable to the Certificateholders on the Distribution Date allocable to principal and premium, if any, and interest, expressed as a dollar amount per $25 Class A Certificate and per $1,000 Notional Amount of Class B Certificates, is as set forth below:

 

Class

Principal

Interest

Total Distribution

A

$

0.000000

$

0.850000

$

0.850000

B

$

0.000000

$

0.375000

$

0.375000

 

2.

The amount of aggregate interest due and not paid as of the Distribution Date is $0.000000.

 

3.

No fees have been paid to the Trustee or any other party from the proceeds of the Term Assets.

 

4.

$54,500,000 aggregate principal amount of Bristol-Myers Squibb Company 6.875% Debentures due August 1, 2097 (the "Term Assets") are held for the above trust.

 

5.

At the close of business on the Distribution Date, 2,180,000 Class A Certificates representing $54,500,000 aggregate Certificate Principal Balance and $54,500,000 aggregate Notional Amount of Class B Certificates were outstanding.

 

6.

The current rating of the Term Assets is not provided in this report. Ratings can be obtained from Standard & Poor's Ratings Services, a division of The McGraw-Hill Companies, Inc., by calling 212-438-2400 and from Moody's Investors Service, Inc. by calling 212-553-0377.

 

 

U.S. Bank Trust National Association, as Trustee

 

 

* The Trustee shall not be held responsible for the selection or use of the CUSIP number nor is any representation made as to its correctness. It is included for the convenience of the Holders.

 

 

5


 

1 Year Str PD 6.80 Bmy Chart

1 Year Str PD 6.80 Bmy Chart

1 Month Str PD 6.80 Bmy Chart

1 Month Str PD 6.80 Bmy Chart

Your Recent History

Delayed Upgrade Clock